The federal Conservatives are urging the Liberal government to do more to ensure that Canadians who received two different doses of COVID-19 vaccines are able to travel internationally.
The federal government is expecting to receive about 7.1 million doses of COVID-19 vaccines this week, as it adjusts its distribution strategy amid waning vaccination rates and substantial supply.
A vaccine study in the United Kingdom reports that getting a dose of the Pfizer-BioNTech vaccine four weeks after a dose of Oxford-AstraZeneca produced a much stronger immune response than two doses of AstraZeneca.
Canadians fully immunized with two shots of the Oxford-AstraZeneca COVID-19 vaccine may now attend a highly anticipated Broadway production featuring Bruce Springsteen, but at least one Canadian hoping to take in the show still has questions about whether or not he can attend.
A new study in England suggests even just one dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines are extremely good at keeping people from ending up in the hospital if they contract COVID-19 from the Delta variant of the virus that causes it.
Prime Minister Justin Trudeau pledged 13 million surplus vaccines to help the world get immunized against COVID-19 as he and other G7 leaders wrapped up a weekend summit in Britain dominated by the pandemic, climate change and China.
Several family doctors and physician associations across Canada say they welcome questions from anyone concerned about second doses of Oxford-AstraZeneca or any other COVID-19 vaccine.
The U.S. Centers for Disease Control and Prevention says people fully vaccinated against COVID-19 no longer need to wear masks outdoors and in most indoor settings, but one of Canada's top public health officials suggests a different approach would be taken here.
Preliminary results of an ongoing study in the United Kingdom suggest alternating the Oxford-AstraZeneca and Pfizer-BioNTech vaccines causes more frequent mild to moderate symptoms, but there are no other safety concerns from mixing those vaccines.
Canadian provinces suspended use of the Oxford-AstraZeneca COVID-19 vaccine in people under age 55 on Monday, March 29, 2021, acting on an advisory committee's concerns about a possible link between the shot and rare blood clots.